CHEIRON PHARMA is a leading
pharmaceutical company with 18 years of
experience in the cosmeceutical field. CHEIRON PHARMA main area of
concentration is the development, manufacturing and marketing of novel, innovative and effective products, focused on
the field of “corneotherapy”.
Since its foundation CHEIRON PHARMA has
diversified, and within a brief period of time, has stood out from the crowd of its
competitors. The reason for this being the
launching, both in Greece and other markets
abroad, a number of unique and effective
“corneotherapy” products, which made an
excellent impression on the physicians
community since they met the unmet medical
needs of the practitioners and their patients.
The Research & Development department, driven by innovation and based on
international medical studies, is engaged in
the development of unique, effective and
safe “corneotherapy” products, which will
expand CHEIRON PHARMA product
portofolio. We are regularly Selling: aquatopix, uronyx, phoebe, pruzax, synurox, lacurex, raxal. |
|
|